This is a preview of subscription content, log in via an institution to check access.
Notes
Reported in 2012 US dollar values from the perspective of the healthcare system as a sum of insurer and patient costs.
Reference
Vale SM, et al. Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update. PharmacoEconomics : 27 Oct 2016. Available from: URL: http://dx.doi.org/10.1007/s40273-016-0462-4
Rights and permissions
About this article
Cite this article
Pharmacoeconomic update on actinic keratosis therapies. PharmacoEcon Outcomes News 766, 25 (2016). https://doi.org/10.1007/s40274-016-3546-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3546-7